![Inside the GENOME artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts113/v4/c8/a1/0e/c8a10ebf-7dab-7dcf-5168-f1009497da93/mza_6788305613998935850.jpg/100x100bb.jpg)
Myriad Live - Let's Talk PRS
Inside the GENOME
English - June 14, 2021 22:00 - 56 minutes - 39 MBMedicine Health & Fitness Science genetics oncology cancer hereditary testing genetic testing brca cancer genetics Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Myriad Oncology Live episodes are recordings of an open-forum webinar hosted by Dr. Thomas Slavin. The opinions and views expressed in this recording do not necessarily represent those of Myriad Genetics or its affiliates. To participate in a future recording, visit myriad-oncology.com/myriad-oncology-live for a list of dates, times, and subjects.
Many studies were referenced in this episode, please see links below:
Yanes T, et al. Clinical applications of Polygenic breast cancer risk: a critical review and perspective of an emerging field. Breast Cancer Res 22, 21 (2020). https://pubmed.ncbi.nlm.nih.gov/32066492/
Mars et al study link: https://www.nature.com/articles/s41467-020-19966-5
Rosner et al study: https://cebp.aacrjournals.org/content/cebp/early/2020/12/04/1055-9965.EPI-20-0900.full.pdf
Lakeman et al study: https://www.nature.com/articles/s41436-020-0884-4
Barnes et al study: https://www.nature.com/articles/s41436-020-0862-x
https://www.nature.com/articles/ng.3841
https://pubmed.ncbi.nlm.nih.gov/25862352/
This is the study where the chart comes from : https://pubmed.ncbi.nlm.nih.gov/32620971/
Here is the abstract from ASCO about ancestrally unbiased breast cancer (BC) risk assessment. Dr. Pederson also presented this material during the meeting. https://meetinglibrary.asco.org/record/197017/abstract
Here is the Tischkowitz paper Dr. Slavin was discussing: https://www.acmg.net/PDFLibrary/41436_2021_1151_OnlinePDF.pdf
Gallagher paper (chart was from this paper) https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2767768
Yanes T, et al. Women's responses and understanding of polygenic breast cancer risk information. Fam Cancer. 2020 Oct;19(4):297-306. https://pubmed.ncbi.nlm.nih.gov/32430685/
Hughes et al paper where data from chart is derived: https://ascopubs.org/doi/full/10.1200/PO.20.00246
Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score https://ascopubs.org/doi/full/10.1200/JCO.20.01992
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer https://www.nejm.org/doi/full/10.1056/NEJMoa2105215